Covered recipient · General Payments record
MAHMOUD SOUBRA
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2020–2024
$702.96
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $253.03 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $96.09 | 4 |
| Celgene Corporation | $87.77 | 3 |
| Braintree Laboratories, Inc. | $38.48 | 2 |
| GENZYME CORPORATION | $30.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.75 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106142322 | CMS |
| ABBVIE INC. | $27.84 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106142324 | CMS |
| ABBVIE INC. | $18.21 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106142326 | CMS |
| ABBVIE INC. | $29.29 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106142328 | CMS |
| Braintree Laboratories, Inc. | $18.87 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125518015 | CMS |
| Braintree Laboratories, Inc. | $19.61 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125518017 | CMS |
| Celgene Corporation | $24.18 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101116834 | CMS |
| Celgene Corporation | $30.94 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101116842 | CMS |
| Celgene Corporation | $32.65 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101116848 | CMS |
| GENZYME CORPORATION | $30.69 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139969519 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.